These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10461568)

  • 41. Neuroimaging in patients with seizures of probable frontal lobe origin.
    Swartz BE; Halgren E; Delgado-Escueta AV; Mandelkern M; Gee M; Quinones N; Blahd WH; Repchan J
    Epilepsia; 1989; 30(5):547-58. PubMed ID: 2507301
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Positron emission tomography with [(18)F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD).
    Henkel K; Zerr I; Hertel A; Gratz KF; Schröter A; Tschampa HJ; Bihl H; Büll U; Grünwald F; Drzezga A; Spitz J; Poser S
    J Neurol; 2002 Jun; 249(6):699-705. PubMed ID: 12111302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of frontal lobe epileptic foci in children using positron emission tomography.
    da Silva EA; Chugani DC; Muzik O; Chugani HT
    Epilepsia; 1997 Nov; 38(11):1198-208. PubMed ID: 9579921
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study.
    Otte A; Weiner SM; Peter HH; Mueller-Brand J; Goetze M; Moser E; Gutfleisch J; Hoegerle S; Juengling FD; Nitzsche EU
    Eur J Nucl Med; 1997 Jul; 24(7):787-91. PubMed ID: 9211766
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings.
    Masangkay N; Basu S; Moghbel M; Kwee T; Alavi A
    Nucl Med Commun; 2014 Oct; 35(10):1038-46. PubMed ID: 25023997
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cerebral fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography (FDG PET), MRI, and clinical observations in a patient with infantile G(M1) gangliosidosis.
    Al-Essa MA; Bakheet SM; Patay ZJ; Nounou RM; Ozand PT
    Brain Dev; 1999 Dec; 21(8):559-62. PubMed ID: 10598059
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maturational changes in cerebral function in infants determined by 18FDG positron emission tomography.
    Chugani HT; Phelps ME
    Science; 1986 Feb; 231(4740):840-3. PubMed ID: 3945811
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Altered frontostriatal relationship in unmedicated schizophrenic patients.
    Biver F; Goldman S; Luxen A; Delvenne V; De Maertelaer V; De La Fuente J; Mendlewicz J; Lotstra F
    Psychiatry Res; 1995 Sep; 61(3):161-71. PubMed ID: 8545500
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Central nervous system malformations in ethylmalonic encephalopathy.
    Nowaczyk MJ; Blaser SI; Clarke JT
    Am J Med Genet; 1998 Jan; 75(3):292-6. PubMed ID: 9475600
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regional cerebral hyperperfusion with ictal dystonic posturing: ictal-interictal SPECT subtraction.
    Joo EY; Hong SB; Lee EK; Tae WS; Kim JH; Seo DW; Hong SC; Kim S; Kim MH
    Epilepsia; 2004 Jun; 45(6):686-9. PubMed ID: 15144436
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cholangiocarcinoma associated with limbic encephalitis and early cerebral abnormalities detected by 2-deoxy-2-[fluorine-18]fluoro-D-glucose integrated with computed tomography-positron emission tomography: a case report.
    Schmidt SL; Schmidt JJ; Tolentino JC; Ferreira CG; de Almeida SA; Alvarenga RP; Simoes EN; Schmidt GJ; Canedo NH; Chimelli L
    J Med Case Rep; 2016 Jul; 10():200. PubMed ID: 27439460
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NMDA-receptor activity visualized with (S)-[N-methyl-11C]ketamine and positron emission tomography in patients with medial temporal lobe epilepsy.
    Kumlien E; Hartvig P; Valind S; Oye I; Tedroff J; Långström B
    Epilepsia; 1999 Jan; 40(1):30-7. PubMed ID: 9924899
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional caudate imaging in symptomatic Huntington's disease: positron emission tomography versus single-photon emission computed tomography.
    Martin WR; Hoskinson M; Kremer B; Maguire C; McEwan A
    J Neuroimaging; 1995 Oct; 5(4):227-32. PubMed ID: 7579751
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task.
    Shihabuddin L; Buchsbaum MS; Hazlett EA; Haznedar MM; Harvey PD; Newman A; Schnur DB; Spiegel-Cohen J; Wei T; Machac J; Knesaurek K; Vallabhajosula S; Biren MA; Ciaravolo TM; Luu-Hsia C
    Arch Gen Psychiatry; 1998 Mar; 55(3):235-43. PubMed ID: 9510217
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of 2- and 3-18F-fluoro-deoxy-D-glucose for studies of tissue metabolism.
    Kearfott KJ; Elmaleh DR; Goodman M; Correia JA; Alpert NM; Ackerman RH; Brownell GL; Strauss WH
    Int J Nucl Med Biol; 1984; 11(1):15-22. PubMed ID: 6610664
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease.
    Petrou M; Davatzikos C; Hsieh M; Foerster BR; Albin RL; Kotagal V; Müller ML; Koeppe RA; Herman WH; Frey KA; Bohnen NI
    Acad Radiol; 2016 May; 23(5):577-81. PubMed ID: 26874576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CT and MR of the brain in the diagnosis of organic acidemias. Experiences from 107 patients.
    Brismar J; Ozand PT
    Brain Dev; 1994 Nov; 16 Suppl():104-24. PubMed ID: 7726375
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.
    Rose DM; Delbeke D; Beauchamp RD; Chapman WC; Sandler MP; Sharp KW; Richards WO; Wright JK; Frexes ME; Pinson CW; Leach SD
    Ann Surg; 1999 May; 229(5):729-37; discussion 737-8. PubMed ID: 10235532
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Positron emission tomography imaging of regional cerebral glucose metabolism.
    Alavi A; Dann R; Chawluk J; Alavi J; Kushner M; Reivich M
    Semin Nucl Med; 1986 Jan; 16(1):2-34. PubMed ID: 2935938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.